# Establishment Labs Holdings Inc. (ESTA)

Source: https://www.quantisnow.com/company/ESTA
Generated: 2026-11-11T12:21:02.538Z

- Ticker: ESTA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Industrial Specialties
- IPO year: 2018
- SEC CIK: 0001688757
- Website: establishmentlabs.com

## About

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

## Latest ESTA news and filings

- 2026-11-06 21:59 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Establishment Labs Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-establishment-labs-holdings-inc-6779434)
- 2026-10-29 12:25 UTC [SEC Form 8-K] [SEC Form 8-K filed by Establishment Labs Holdings Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-establishment-labs-holdings-inc-6762753)
- 2026-10-29 12:00 UTC [Earnings Date] [Establishment Labs® Reports Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/establishment-labs-reports-third-quarter-2026-financial-results-6762631)
- 2026-10-19 12:00 UTC [Earnings Date] [Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29](https://www.quantisnow.com/insight/establishment-labs-to-announce-third-quarter-2026-financial-results-on-6750128)
- 2026-10-15 12:50 UTC [Analyst Coverage Initiated] [Stifel initiated coverage on Establishment Labs with a new price target](https://www.quantisnow.com/insight/stifel-initiated-coverage-on-establishment-labs-with-a-new-price-6747495)
- 2026-10-15 10:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by Establishment Labs Holdings Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-establishment-labs-holdings-inc-6747097)
- 2026-10-05 12:00 UTC [Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®](https://www.quantisnow.com/insight/establishment-labs-receives-fda-approval-for-additional-sizes-of-motiva-6735993)
- 2026-10-02 21:14 UTC [SEC Form 4] [Director Gillin Leslie was granted 262 shares, increasing direct ownership by 1% to 18,856 units (SEC Form 4)](https://www.quantisnow.com/insight/director-gillin-leslie-was-granted-262-shares-increasing-direct-ownership-6735238)
- 2026-10-02 21:11 UTC [SEC Form 4] [Director Schutter Edward J was granted 253 shares, increasing direct ownership by 0.14% to 178,205 units (SEC Form 4)](https://www.quantisnow.com/insight/director-schutter-edward-j-was-granted-253-shares-increasing-direct-6735224)
- 2026-10-02 21:10 UTC [SEC Form 4] [Director Lewin Nicholas Sheridan was granted 389 shares, increasing direct ownership by 0.04% to 1,080,349 units (SEC Form 4)](https://www.quantisnow.com/insight/director-lewin-nicholas-sheridan-was-granted-389-shares-increasing-direct-6735221)
- 2026-10-02 21:09 UTC [SEC Form 4] [Director Slotkin Bryan was granted 253 shares, increasing direct ownership by 0.77% to 33,052 units (SEC Form 4)](https://www.quantisnow.com/insight/director-slotkin-bryan-was-granted-253-shares-increasing-direct-ownership-6735216)
- 2026-10-02 21:07 UTC [SEC Form 4] [Director Custin Ann was granted 301 shares, increasing direct ownership by 1% to 24,626 units (SEC Form 4)](https://www.quantisnow.com/insight/director-custin-ann-was-granted-301-shares-increasing-direct-ownership-6735196)
- 2026-09-21 12:00 UTC [Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants](https://www.quantisnow.com/insight/establishment-labs-highlights-new-breast-tissue-preservation-data-and-announces-6721248)
- 2026-08-26 21:06 UTC [SEC Form 4] [Chief Executive Officer Caldini Filippo covered exercise/tax liability with 682 shares, decreasing direct ownership by 1% to 48,829 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/chief-executive-officer-caldini-filippo-covered-exercisetax-liability-with-682-6695911)
- 2026-08-13 12:24 UTC [Analyst Upgrade] [Establishment Labs upgraded by Citigroup with a new price target](https://www.quantisnow.com/insight/establishment-labs-upgraded-by-citigroup-with-a-new-price-target-6679493)
- 2026-08-12 13:15 UTC [The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For](https://www.quantisnow.com/insight/the-glp-1-boom-created-a-tissue-gap-fillers-were-not-6677280)
- 2026-08-07 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Establishment Labs Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-establishment-labs-holdings-inc-6671491)
- 2026-08-06 12:04 UTC [SEC Form 8-K] [Establishment Labs Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/establishment-labs-holdings-inc-filed-sec-form-8-k-results-of-6667510)
- 2026-08-06 12:00 UTC [Earnings Date] [Establishment Labs® Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/establishment-labs-reports-second-quarter-2026-financial-results-6667430)
- 2026-07-31 21:00 UTC [SEC Form SCHEDULE 13G filed by Establishment Labs Holdings Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-establishment-labs-holdings-inc-6658176)
- 2026-07-23 12:00 UTC [Earnings Date] [Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6](https://www.quantisnow.com/insight/establishment-labs-to-announce-second-quarter-2026-financial-results-on-6646286)
- 2026-07-10 20:27 UTC [SEC Form 4] [Director Chacon Quiros Juan Jose was granted 11,315 shares, increasing direct ownership by 25% to 56,508 units (SEC Form 4)](https://www.quantisnow.com/insight/director-chacon-quiros-juan-jose-was-granted-11315-shares-increasing-6634225)
- 2026-07-10 20:26 UTC [SEC Form 4] [SEC Form 4 filed by Director Lewin Nicholas Sheridan](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-lewin-nicholas-sheridan-6634217)
- 2026-07-01 22:10 UTC [SEC Form 4] [Amendment: Director Harris Taylor C. was granted 3,722 shares (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-harris-taylor-c-was-granted-3722-shares-sec-6623686)
- 2026-07-01 22:08 UTC [SEC Form 4] [Director Gillin Leslie was granted 196 shares, increasing direct ownership by 1% to 18,594 units (SEC Form 4)](https://www.quantisnow.com/insight/director-gillin-leslie-was-granted-196-shares-increasing-direct-ownership-6623683)
- 2026-07-01 22:07 UTC [SEC Form 4] [Director Custin Ann was granted 239 shares, increasing direct ownership by 0.99% to 24,325 units (SEC Form 4)](https://www.quantisnow.com/insight/director-custin-ann-was-granted-239-shares-increasing-direct-ownership-6623680)
- 2026-07-01 22:06 UTC [SEC Form 4] [Director Lewin Nicholas Sheridan was granted 291 shares, increasing direct ownership by 0.03% to 1,079,960 units (SEC Form 4)](https://www.quantisnow.com/insight/director-lewin-nicholas-sheridan-was-granted-291-shares-increasing-direct-6623679)
- 2026-07-01 22:06 UTC [SEC Form 4] [Director Schutter Edward J was granted 216 shares, increasing direct ownership by 0.12% to 177,952 units (SEC Form 4)](https://www.quantisnow.com/insight/director-schutter-edward-j-was-granted-216-shares-increasing-direct-6623678)
- 2026-07-01 22:05 UTC [SEC Form 4] [Director Slotkin Bryan was granted 189 shares, increasing direct ownership by 0.58% to 32,799 units (SEC Form 4)](https://www.quantisnow.com/insight/director-slotkin-bryan-was-granted-189-shares-increasing-direct-ownership-6623677)
- 2026-07-01 13:05 UTC [A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity](https://www.quantisnow.com/insight/a-nasdaq-listed-regenerative-tissue-company-just-opened-a-lab-the-6622187)
- 2026-06-29 21:34 UTC [SEC Form 4] [Director Harris Taylor C. was granted 3,230 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-harris-taylor-c-was-granted-3230-shares-sec-form-6619496)
- 2026-06-29 21:32 UTC [SEC Form 3] [SEC Form 3 filed by new insider Harris Taylor C.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-harris-taylor-c-6619490)
- 2026-06-29 12:05 UTC [SEC Form 8-K] [Establishment Labs Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/establishment-labs-holdings-inc-filed-sec-form-8-k-leadership-update-6618343)
- 2026-06-29 12:00 UTC [Leadership Update] [Establishment Labs® Appoints Taylor Harris to Board of Directors](https://www.quantisnow.com/insight/establishment-labs-appoints-taylor-harris-to-board-of-directors-6618308)
- 2026-06-25 13:04 UTC [The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It](https://www.quantisnow.com/insight/the-aesthetics-giants-just-confirmed-ozempic-face-is-real-and-6615387)
- 2026-06-25 12:00 UTC [Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index](https://www.quantisnow.com/insight/establishment-labs-added-to-membership-of-us-small-cap-russell-2000-6615151)
- 2026-06-16 12:15 UTC [Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower](https://www.quantisnow.com/insight/fresh-off-its-nasdaq-debut-a-regenerative-medicine-upstart-is-stacking-6604026)
- 2026-05-29 00:49 UTC [SEC Form 4] [See footnote 3 Jw Asset Management, Llc sold $6,636,886 worth of shares (90,533 units at $73.31) (SEC Form 4)](https://www.quantisnow.com/insight/see-footnote-3-jw-asset-management-llc-sold-6636886-worth-6578061)
- 2026-05-27 13:00 UTC [Leadership Update] [After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead](https://www.quantisnow.com/insight/after-fifty-years-of-implants-a-newly-public-biotech-is-6574089)
- 2026-05-26 20:06 UTC [SEC Form 4] [Director Schutter Edward J was granted 2,354 shares, increasing direct ownership by 1% to 177,736 units (SEC Form 4)](https://www.quantisnow.com/insight/director-schutter-edward-j-was-granted-2354-shares-increasing-direct-6572151)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ESTA
- Earnings history: https://www.quantisnow.com/earnings/ESTA
- Dividend history: https://www.quantisnow.com/dividends/ESTA
- Insider transactions: https://www.quantisnow.com/insiders/ESTA
- Options chain: https://www.quantisnow.com/options/ESTA
- SEC 8-K filings only: https://www.quantisnow.com/company/ESTA/8-k
- RSS and alerts for ESTA: https://www.quantisnow.com/docs/rss-feeds.md